Related Experiment Video

Updated: May 6, 2026

Assessing Cellular Target Engagement by SHP2 PTPN11 Phosphatase Inhibitors
08:45

Assessing Cellular Target Engagement by SHP2 PTPN11 Phosphatase Inhibitors

Published on: July 17, 2020

5.7K

Hsp27 as a therapeutic target in cancers

Julie Acunzo, Claudia Andrieu, Virginie Baylot

  • 1The Centre de Recherche en Cancerologie de Marseille (CRCM), UMR1068 Inserm, Institut Paoli- Calmette, Aix-Marseille Universite, 27 Boulevard Lei Roure BP30059, 13273 Marseille Cedex 9, France. palma.rocchi@inserm.fr.

Current Drug Targets
|October 22, 2013
PubMed

Insights

Heat shock protein 27 (Hsp27) is a stress-activated protein that promotes cancer cell survival and treatment resistance. Targeting Hsp27 offers a promising strategy for improving cancer therapy outcomes.

Area of Science:

  • Molecular Biology
  • Oncology
  • Biochemistry

Background:

  • Heat shock protein 27 (Hsp27) is a stress-inducible protein with chaperone and antioxidant functions.
  • Hsp27 inhibits apoptosis and remodels the actin cytoskeleton.
  • Elevated Hsp27 levels in cancer correlate with poor prognosis and therapeutic resistance.

Purpose of the Study:

  • To review recent findings on the role of Hsp27 in cancer.
  • To explore strategies for targeting and inhibiting Hsp27 in clinical settings.

Main Methods:

  • Literature review of recent studies on Hsp27 in cancer.
  • Analysis of Hsp27's mechanisms in cancer progression and treatment resistance.

Main Results:

  • Hsp27's upregulation in various cancers contributes to cell survival.
  • Hsp27 protects cancer cells from apoptosis induced by therapeutic agents.
  • Hsp27 is implicated in resistance to chemotherapy and radiotherapy.

Conclusions:

  • Hsp27 is a significant factor in cancer development and treatment failure.
  • Inhibiting Hsp27 represents a potential therapeutic approach for overcoming cancer resistance.

More Related Videos

RNA Interference-based Investigation of the Function of Heat Shock Protein 27 during Corneal Epithelial Wound Healing08:34

RNA Interference-based Investigation of the Function of Heat Shock Protein 27 during Corneal Epithelial Wound Healing

Published on: September 27, 2016

6.7K
Evaluation of Abnormal Growth-related Genes of Hematopoietic Stem and Progenitor Cells by Combining CRISPR/Cas9 Technology with Cell Counting07:01

Evaluation of Abnormal Growth-related Genes of Hematopoietic Stem and Progenitor Cells by Combining CRISPR/Cas9 Technology with Cell Counting

Published on: May 2, 2025

834

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.1K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

1.5K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.0K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.0K